"The Ministry of Industry and Trade of the Russian Federation has established a plan for the activities of the FSUE Moscow Endocrine Plant ". Despite the fact that the year was extremely financially strained, the Enterprise implemented the plan for 103.5%,” said Yu.A. Bozhkov, the chief accountant of the FSUE Moscow State Endocrine Plant. - For to the main directive indicator of its work - the volume of gross sales revenue, the implementation amounted to 2825 million roubles".
Net profit in the amount of 162 million roubles was received, from which the major part will be used as a source of financing of capital investments in 2017, 25% of the net profit will be transferred to federal budget revenue.
According to the results of the year, the Enterprise put into operation fixed assets used in production activities in the amount of 100 million roubles, net assets, as own sources of funds of the Enterprise, increased by 151 million roubles over the year and reached 2335 million roubles.
The Enterprise has a high level of financial stability, provides liquidity for all current and subsequent obligations, follows the path of innovative development, improvement of the quality and competitiveness of products, and masters new areas of activity.
The indicators achieved over the past three years indicate a high profitability of financial investments in the development of the FSUE Moscow Endocrine Plant, which, in turn, makes it an investment-attractive enterprise.
Comment type is not specified in the component properties.